WELCOME TO The HEALTHCARE REPORT
Blue Cross Blue Shield of Massachusetts
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Kepro | October 01, 2021
Kepro announced today that it has completed the acquisition of eQHealth Solutions, LLC. This acquisition will expand Kepro's population health management and technology solution portfolios.
"Today we welcome eQHealth Solutions to the Kepro family. The combination of our companies will support our continued growth and bring further expertise, depth, and tech-enabled solutions to our clients to better serve priority populations."
Exela Technologies | January 12, 2022
Exela Technologies, Inc. (“Exela”)today announced that it continues to expand its relationship with a leading health insurance organization that spans almost two decades. This customer continues to accelerate deployment of Exela’s PCH Global platform to speed up their digital transformation and improve both the member and provider experience. The latest expansion is valued at $6.2 million of additional contract value revenue.
Exela continues to invest in expa...
PR Newswire | July 06, 2020
Telehealth has exploded as a way to continue patient care during COVID-19, and new research from leading healthcare analytics firm Healthmonix, reveals almost 80% of healthcare practices and hospital systems are using telehealth during the COVID-19 pandemic. Close to 60% of telehealth facilitators fell into one of two categories: Those that indicated over 51% of their practice was now telehealth (28%) and those that appeared to just be entering telehealth and were experiencing a 1-9% increase (3...
Alkem Laboratories Ltd. | January 13, 2022
Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval. This advanced technology for DFU management has a high scope of preventing amputations in diabetic patients. This te...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE